Insider at NTRA (NASDAQ: NTRA) files notice to sell company shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
An affiliate of the issuer, Michael Brophy, filed a Form 144 notice to sell 5,671 shares of common stock through Morgan Stanley Smith Barney on NASDAQ. These shares were acquired as restricted stock units on 09/28/2025, when payment was recorded as non-cash (N/A).
The filing notes that 138,014,465 common shares were outstanding and lists several sales during the prior three months, including transactions under a Rule 10b5-1 sales plan and direct sales, with individual trades as large as 36,573 and 23,948 shares of common stock.
Positive
- None.
Negative
- None.
FAQ
What type of NTRA securities are involved in Michael Brophy’s planned sale?
The planned sale involves common stock of the issuer. The Form 144 lists the class as “Common” and indicates that 5,671 common shares, originally received as restricted stock units, are expected to be sold on NASDAQ through Morgan Stanley Smith Barney’s Executive Financial Services platform.
What recent NTRA stock sales by Michael Brophy or his plans are disclosed?
The notice lists several common stock sales in the past three months. These include trades under a Rule 10b5-1 sales plan and direct sales, with individual transactions such as 36,573 shares and 23,948 shares of common sold in January 2026, generating multi-million-dollar gross proceeds.